Clinical trial
Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major…
NCT00143091 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00143091 |
|---|---|
| Title | Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder |
| Official title | A Six-Week, Fixed Dose, Double-Blind, Double-Dummy, Placebo and Sertraline Controlled, Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Outpatients With Major Depressive Disorder |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Depressive Disorder, Major |
| Intervention type | Drug |
| Interventions | CP-316, 311, Placebo, Sertraline |
| Enrollment | 200 |
| Start date | Apr 1, 2005 |
| Completion | Apr 1, 2006 |
| First posted | Sep 2, 2005 |
| Last update posted | Mar 24, 2008 |
| Countries | Russia, Serbia and Montenegro, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: